Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological malignancy
with an aggressive clinical course. It is grouped with acute myeloid leukemia–related …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an exceedingly rare disorder
categorized under acute myeloid leukemia by the World Health Organization …

Background Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematological
malignancy with an aggressive clinical course. Most patients with BPDCN have skin lesions …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy
arising from the aberrant transformation of plasmacytoid dendritic cells (pDCs) and involving …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is an aggressive hematologic
malignancy originating from the precursor of the plasmacytoid dendritic cell. It is very rare …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare myeloid malignancy with no
defined standard of care. BPDCN presents most commonly with skin lesions with or without …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a clinically aggressive tumor,
which frequently presents as cutaneous lesions and subsequently progresses to bone …

Blastic plasmacytoid dendritic cell neoplasm is a rare entity grouped with the acute myeloid
leukemia–related precursor neoplasms in the 2008 World Health Organization classification …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and highly aggressive
hematological malignancy derived from precursors of plasmacytoid dendritic cells. Very few …

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive
hematopoietic malignancy mainly affecting elderly patients. Most patients present with …